Drug intelligence / Profile preview

cefalonium

Development stage
Unknown
Modality
Small Molecules
Administration
Intramammary
01

Overview

Cefalonium is a first-generation, semi-synthetic cephalosporin antibiotic belonging to the β-lactam class. It exhibits broad-spectrum bactericidal activity against Gram-positive and some Gram-negative bacteria, including *Staphylococcus aureus* (including penicillin-resistant strains), *Streptococcus* species, *Escherichia coli*, *Klebsiella* spp., and others commonly associated with bovine mastitis. Its primary mechanism of action is inhibition of bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), thereby interfering with the final phase of peptidoglycan synthesis and leading to cell lysis and death. Cefalonium is primarily used in veterinary medicine for routine dry cow therapy—to treat existing subclinical infections and prevent new intramammary infections during the dry period in dairy cattle.

Brand names
Cepravin
Other names
cephalonium
02

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on cefalonium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cefalonium.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call